Clinical Trial Update: Safety and Immune Response Study of the Vaccine ALVAC vCP1452 Alone or in Combination With AIDSVAX B/B [Phase 2]

View source ↗

Summary

Phase 2 safety and immune response study of ALVAC vCP1452 alone or with AIDSVAX B/B in HIV infection completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• AIDSVAX B/B
• ALVAC vCP1452

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 2 | Status: COMPLETED